StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.01+0.03 (+3.30%)

Close on Nov 17, 2026Market cap $19.46MP/E –Yield –

Cocrystal Pharma total assets

Total assets on the balance sheet at the end of each period.

Cocrystal Pharma's total assets was $4.65M at Jun 30, 2026. For fiscal 2025 it was $9.71M, down 27.8% from the year before. Over ten years it grew -26.9% a year on average. The highest annual figure on record is $259.28M in fiscal 2014.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.71M-27.8%
FY2024Dec 31, 2024$13.46M-57.0%
FY2023Dec 31, 2023$31.26M-23.5%
FY2022Dec 31, 2022$40.84M-48.6%
FY2021Dec 31, 2021$79.39M+46.4%
FY2020Dec 31, 2020$54.24M+90.1%
FY2019Dec 31, 2019$28.53M-58.4%
FY2018Dec 31, 2018$68.56M-43.5%
FY2017Dec 31, 2017$121.43M-2.8%
FY2016Dec 31, 2016$124.88M-44.3%
FY2015Dec 31, 2015$224.23M-13.5%
FY2014Dec 31, 2014$259.28M+15510.1%
FY2013Dec 31, 2013$1.66M-77.1%
FY2012Dec 31, 2012$7.24M-4.1%
FY2011Dec 31, 2011$7.55M+0.2%
FY2010Dec 31, 2010$7.53M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.65M-45.3%
Q1 FY2026Mar 31, 2026$7.43M-30.3%
Q4 FY2025Dec 31, 2025$9.71M-27.8%
Q3 FY2025Sep 30, 2025$10.45M-35.6%
Q2 FY2025Jun 30, 2025$8.51M-60.6%
Q1 FY2025Mar 31, 2025$10.66M-59.8%
Q4 FY2024Dec 31, 2024$13.46M-57.0%
Q3 FY2024Sep 30, 2024$16.23M-50.2%
Q2 FY2024Jun 30, 2024$21.57M-40.5%
Q1 FY2024Mar 31, 2024$26.55M-29.8%
Q4 FY2023Dec 31, 2023$31.26M-23.5%
Q3 FY2023Sep 30, 2023$32.61M-28.6%
Q2 FY2023Jun 30, 2023$36.28M-30.7%
Q1 FY2023Mar 31, 2023$37.84M-49.8%
Q4 FY2022Dec 31, 2022$40.84M-48.6%
Q3 FY2022Sep 30, 2022$45.65M-44.7%
Q2 FY2022Jun 30, 2022$52.38M-40.1%
Q1 FY2022Mar 31, 2022$75.37M+40.0%
Q4 FY2021Dec 31, 2021$79.39M+46.4%
Q3 FY2021Sep 30, 2021$82.60M+55.2%
Q2 FY2021Jun 30, 2021$87.42M+116.0%
Q1 FY2021Mar 31, 2021$53.85M+25.7%
Q4 FY2020Dec 31, 2020$54.24M+90.1%
Q3 FY2020Sep 30, 2020$53.22M-27.5%
Q2 FY2020Jun 30, 2020$40.48M-46.0%
Q1 FY2020Mar 31, 2020$42.84M-43.8%
Q4 FY2019Dec 31, 2019$28.53M-58.4%
Q3 FY2019Sep 30, 2019$73.44M-40.9%
Q2 FY2019Jun 30, 2019$74.91M-40.7%
Q1 FY2019Mar 31, 2019$76.29M-36.8%
Q4 FY2018Dec 31, 2018$68.56M-43.5%
Q3 FY2018Sep 30, 2018$124.17M+1.6%
Q2 FY2018Jun 30, 2018$126.33M+1.6%
Q1 FY2018Mar 31, 2018$120.72M-1.5%
Q4 FY2017Dec 31, 2017$121.43M-2.8%
Q3 FY2017Sep 30, 2017$122.25M-44.7%
Q2 FY2017Jun 30, 2017$124.34M–
Q1 FY2017Mar 31, 2017$122.52M–
Q4 FY2016Dec 31, 2016$124.88M–
Q3 FY2016Sep 30, 2016$220.90M–

More Cocrystal Pharma figures

See a number that looks wrong?